Protocol Ledger

NCT04879615 · Phase III · COMPLETED

24 Hours Treatment with Alteplase in Patients with Ischemic Stroke

Interventional Phase III clinical trial protocol NCT04879615 sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-06-21 Enrollment: 372 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04879615
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)372 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04879615
Protocol FieldVerified Registry Value
NCT IdentifierNCT04879615
Consolidated Lead SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment372 participants (ACTUAL)
Registered Start Date2021-06-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04879615
Hospital Research SiteLocationSite Profile
The First Affiliated Hospital Of Soochow UniversitySuzhou, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI